← Back to Test

Problem 4 - Olympiad

Two medical researchers present conflicting interpretations of a new drug trial for a chronic disease. Researcher P claims the drug is highly effective, citing a statistically significant reduction in symptoms in the treatment group compared to the placebo. Researcher Q argues the drug is not genuinely effective, stating that the perceived benefit is due to a large placebo effect combined with poor blinding of the study participants. To reconcile their viewpoints, which piece of additional information would be most crucial to investigate?

Correct: B

Researcher Q specifically points to 'poor blinding of the study participants' and a 'large placebo effect' as reasons for doubting the drug's effectiveness. Investigating the methodology for participant blinding and placebo administration (Choice B) would directly address Researcher Q's concerns about the study's design and its potential to inflate perceived effectiveness. If the blinding was indeed poor, it would support Researcher Q's skepticism. If it was robust, it would weaken Researcher Q's argument and strengthen Researcher P's.